Phase I/II Study of 5-azacitidine in Combination With Vorinostat in Patients With Relapsed or Refractory DLBCL.
Phase of Trial: Phase I/II
Latest Information Update: 12 Apr 2017
At a glance
- Drugs Azacitidine; Vorinostat
- Indications Diffuse large B cell lymphoma
- Focus Adverse reactions
- 27 Jan 2017 Status changed from recruiting to completed.
- 27 Oct 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 27 Oct 2010 Actual initiation date (Sep 2010) added as reported by ClinicalTrials.gov.